Insider · CIK 0001796310
Connealy Pamela Ann
cfocooofficer
Files at PYXS (Pyxis Oncology, Inc.). First filing Nov 27, 2024, latest Nov 27, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$174k bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 36Weak | buy | PYXS Pyxis Oncology, Inc. | $174k | 88,850 | +8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | PYXS Pyxis Oncology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +310,000 | $0.00 | $0 | 310,000 | Dec 23, 2024 |
| Nov 26, 2024 | PYXS Pyxis Oncology, Inc. | POpen-market purchase Common Stockindirect: By Trust | +5,450 | $2.00 | $11k | 1,115,743 | Nov 27, 2024 |
| Nov 26, 2024 | PYXS Pyxis Oncology, Inc. | POpen-market purchase Common Stockindirect: By Spouse | +83,400 | $1.96 | $163k | 1,199,143 | Nov 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.